Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 5, Issue 3

Abstract

Background: Heart failure is a complex clinical syndrome, impairing the ability of the cardiac ventricles to fill with or eject blood. Drug therapy for Chronic Heart Failure (CHF) is aimed at providing symptomatic relief and has to be continued indefinitely. Currently Angiotensin Converting Enzyme Inhibitor (ACEI), beta blocker and diuretic form the basis of treatment for CHF. These drugs can cause a wide array of electrolyte disturbances which frequently result in potentially dangerous complications. Early identification of these electrolyte disturbances and knowledge of the pathophysiological mechanisms underlying them will help in the effective management of these patients, when complex combinations of drugs are used. Objectives: 1.To estimate the serum sodium and potassium levels in ‘stable’ Chronic Heart Failure (CHF) patients on treatment. 2. To study the impact of Angiotensin Converting Enzyme inhibitors (ACEI), beta blockers and spironolactone with or without furosemide on serum sodium and potassium levels in stable CHF patients receiving the above drugs. Materials and Methods: A cross-sectional study was conducted on 120 stable chronic heart failure patients. In this, 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers, spironolactone and furosemide, while the other 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers and spironolactone regimen. Serum creatinine, sodium and potassium levels were analyzed in both the group. Conclusion: Majority of the drugs used in the treatment of CHF cause electrolyte disturbances. Hyponatremia in patients receiving all the four drugs and hyperkalemia in patients receiving only three drugs, was observed in our study.

Authors and Affiliations

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri

Keywords

Related Articles

Role of Serum zinc in chronic tonsillitis – A case control study

Background: Chronic tonsillitis is the chronic inflammation of the palatine tonsils. It is a chronic inflammatory process where the immune system is altered leading to low antioxidants level. Zinc acts by maintaining tis...

Evaluation of oxidative stress markers and antioxidant status in smokers

Aims and objective: Evaluation of oxidative stress markers and antioxidant status in Smokers. Material and methods: Study was conducted in Department of Biochemistry, LTMMC Sion Mumbai. 60 chronic smokers were tested for...

Fasting blood sugar and post prandial blood sugar among diabetics at a tertiary care hospital

Background: Patients with IFG and IGT are now referred to as having ‘pre-diabetes’ indicating relatively high risk for development of diabetes in these patients. In the absence of pregnancy, IFG and IGT are risk factors...

Prevalence of metabolic syndrome among younger population by modified NCEP ATP III and IDF criteria

Background: Prevalence of metabolic syndrome in various countries in South Asia is increasing, due to rapid nutritional and lifestyle transition in urbanized areas. Different guidelines issued by NCEP-ATP III and IDF hav...

A study of higher circulatory levels of uric acid in cardio vascular disease (CVD) patients

Uric acid is an end product of purine catabolism. It is observed that increased uric acid formation is associated with various inflammatory conditions. Anthropometric parameters as well lipid profile did not show any cor...

Download PDF file
  • EP ID EP486163
  • DOI 10.26611/10025310
  • Views 197
  • Downloads 0

How To Cite

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri (2018). Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens. Medpulse International Journal of Biochemistry, 5(3), 116-119. https://europub.co.uk/articles/-A-486163